Labiana Health

Labiana Health Liabilities

The The Liabilities of Labiana Health (LAB.MC) as of Oct 21, 2026 is 52.79 M EUR. In the previous year, The Liabilities was 49.43 M EUR — a change of 6.78% (higher).

Liabilities

52.79 MEUR

YoY

6.78%

Last updated:

In 2025, Labiana Health's total liabilities amounted to 52.79 M EUR, a 6.78% difference from the 49.43 M EUR total liabilities in the previous year.

The Labiana Health Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
32.74 M EUR
Jan 1, 2019
50.60 M EUR
Jan 1, 2021
56.84 M EUR
Jan 1, 2022
53.04 M EUR
Jan 1, 2023
55.72 M EUR
Jan 1, 2024
49.43 M EUR
Jan 1, 2025
52.79 M EUR
The Labiana Health Liabilities history
YEARLiabilitiesYoY
52.79 MEUR+6.78%
49.43 MEUR-11.28%
55.72 MEUR+5.06%
53.04 MEUR-6.70%
56.84 MEUR+12.34%
50.60 MEUR+54.57%
32.74 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Labiana Health Stock analysis

What does Labiana Health do? Labiana Health SA generates revenue through the development, manufacturing, and marketing of animal and human medicines. The company focuses on drug research and development, including galenic and analytical development, as well as drug manufacturing, which encompasses formulation development and bacterial vaccine manufacturing. Regulatory services for pharmaceutical product registration in global markets also contribute to its income. Its subsidiaries operate in Ecuador, Mexico, Serbia, and Turkey, serving markets for both animal and human pharmaceutical products. The company's primary products include sterile and lyophilized dosage forms, which are manufactured for use in animal and human medicine. These products are sold to customers in the pharmaceutical industry, including distributors and healthcare providers in the regions where Labiana Health SA has a presence. The company’s R&D and manufacturing capabilities support the production of medicines that meet regulatory standards for global markets. Labiana Health SA’s business model relies on its subsidiaries in Ecuador, Mexico, Serbia, and Turkey to facilitate market access and distribution. The company’s revenue streams are derived from the sale of pharmaceutical products, regulatory services, and the development of new drug formulations. Its focus on sterile and lyophilized dosage forms positions it within the specialized pharmaceutical manufacturing sector, targeting both animal and human medicine segments. Labiana Health is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Labiana Health's Liabilities

Labiana Health's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Labiana Health's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Labiana Health's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Labiana Health's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Labiana Health’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Labiana Health stock

The Liabilities of Labiana Health is 52.79 M EUR in 2025.

The Liabilities of Labiana Health changed from 49.43 M EUR to 52.79 M EUR, representing a 6.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Labiana Health since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Labiana Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Labiana Health

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Labiana Health